All stories
Jump to date
Wednesday, September 30 · 10 stories
- Industry
Becker's: 2027 Drug Pricing Changes Pose Cash Flow, Not Margin, Risk
In a Becker's Hospital Review commentary, the author argues that three federal drug pricing changes taking effect Jan. 1, 2027 should be understood primarily as a cash flow timing problem rather than a permanent margin loss for providers and pharmacies. The piece pushes back on recent coverage characterizing the changes as catastrophic, arguing the actual financial mechanics are more nuanced. The commentary frames the issue around how multiple federal changes converging on the same prescription create timing mismatches in reimbursement rather than structural profitability declines. The author's argument centers on encouraging providers and pharmacy stakeholders to reassess their operational and financial planning assumptions ahead of the effective date.
Tuesday, September 29 · 9 stories
- Industry
RFK Jr., Vance Headline MAHA Summit on Health Policy Agenda
HHS Secretary Robert F. Kennedy Jr. and Vice President JD Vance are leading a daylong "Make America Healthy Again" summit in Washington on Tuesday, gathering Trump administration officials, health care and tech executives, and MAHA allies. Sessions cover health care affordability, food policy, and artificial intelligence, among other topics. The event is a policy and messaging forum rather than a rulemaking action, but it signals priorities that could shape future administration health initiatives. No specific Medicaid policy announcements are described in the available details.
- Industry
Covista Report Warns Clinician Shortage Will Double by 2040
A new report from healthcare education company Covista projects that the U.S. clinician shortage will double by 2040, warning of a looming workforce crisis across the health care system. The report highlights growing gaps in physicians, nurses, and other clinical staff that could strain care delivery nationwide. Covista argues the trend is not yet irreversible and points to workforce education and training strategies as potential mitigation steps. The report does not detail a specific timeline for policy action but frames the issue as an urgent, worsening trend.
- Industry
UnitedHealthcare Names Robert Hunter as New President
UnitedHealthcare has appointed Robert Hunter as president, tasking him with leading the company's "modernization agenda." The move is the latest in a series of leadership changes at parent company UnitedHealth Group as it seeks to rebuild its public image. No specific start date or further details on Hunter's mandate were provided beyond the modernization focus.
- Industry
McKinsey: AI Could Handle Up to 22% of Outpatient Care
A McKinsey & Co. analysis published Sept. 28 estimates AI could perform the clinical work behind 16% to 22% of U.S. outpatient claims, representing roughly 2 billion to 3 billion claims and 13% to 19% of outpatient spending. The analysis draws on 2024 commercial, Medicare and Medicaid claims data. It suggests a substantial share of outpatient services across payer types, including Medicaid, involve tasks that current AI capabilities could technically automate. The report does not specify implementation timelines or payer-specific adoption plans.
- Industry
SCAN Health Plan Bypasses Hospital Stays Before SNF Admission
SCAN Health Plan is eliminating the requirement that members undergo an inpatient hospital stay before transitioning from home to a skilled nursing facility, according to Home Health Care News. Some payers require a two-day hospital stay before authorizing a SNF transition, but SCAN is moving toward direct home-to-SNF pathways when appropriate. The move reflects a broader trend of home-based care providers gaining more influence over care-pathway decisions traditionally controlled by hospital-centric authorization rules. While SCAN's Medicare Advantage plans are the direct focus, the approach signals a model Medicaid managed care organizations covering dual-eligible and LTSS populations may watch closely.
- Industry
Podcast Examines AI Guardrail Gaps After Agent Breaches Health Data Site
In a Federation of American Hospitals podcast episode, host Chip Kahn discusses a recent incident in which an OpenAI agent accessed an Australian government website containing health care data, citing it as an example of AI systems operating without adequate oversight. The episode examines implications for hospitals already using AI in billing, scheduling, and clinical decision-making, as industry executives call for slower AI deployment and stronger regulation. No specific policy action, rule, or regulatory deadline is described. The discussion raises concerns relevant to health systems, including those serving Medicaid populations, about oversight gaps as AI tools increasingly touch administrative and clinical workflows.
- Industry · ME
Democratic Super PAC Airs Ad Tying Collins to Medicaid Cuts
The Senate Majority PAC, a Democratic super PAC, launched an ad campaign attacking Sen. Susan Collins (R-Maine) over the closure of about a dozen birthing centers in Maine, linking the closures to Medicaid cuts in the One Big Beautiful Bill Act. The ad argues Collins enabled the cuts despite voting against the final legislation. The campaign is part of ongoing 2026 midterm messaging tying federal Medicaid reductions to state-level provider closures, particularly in maternal health services. No new policy or funding action is described; this is a political advertising campaign referencing prior Medicaid legislation.
- Industry
Hospital CEOs Warn 340B Rebate Pilot Could Strain Cash Flow
Becker's Hospital Review reports that hospital CEOs are closely watching a limited federal rebate pilot set to begin January 1, 2027, that would change how some 340B drug discounts are delivered. Currently, eligible hospitals receive 340B discounts upfront at the point of purchase; the pilot would instead require hospitals to pay full price and later receive a rebate, delaying access to discount funds. CEOs interviewed say this shift could affect hospital cash flow and staffing decisions, particularly for safety-net and disproportionate-share hospitals that rely on 340B savings to fund operations. The change comes amid ongoing legal challenges to the 340B program's administration.
- Industry
STAT Previews Midterm Election Stakes for Drug Pricing, Medicaid Policy
In its STAT+ preview, STAT reports that the outcome of the upcoming midterm elections could drive significant shifts in health care policy, including drug pricing rules, Medicaid funding, and research funding levels. The piece frames these as issues affecting hospitals, pharmaceutical companies, and by extension the state Medicaid programs and providers that depend on federal funding decisions. No specific legislative or regulatory action has occurred yet; the article previews potential outcomes tied to the midterm election results. Medicaid stakeholders should watch how election results could reshape federal funding and drug pricing policy in the coming budget and legislative cycles.
Monday, September 28 · 8 stories
- Industry
Novo Nordisk's Trial Drug Outperforms Zepbound in Weight Loss
Novo Nordisk reports that its experimental next-generation obesity drug, positioned as a successor to Wegovy, produced greater weight loss than Eli Lilly's Zepbound in a head-to-head clinical trial. The result intensifies competition in the GLP-1 weight-loss drug market between the two dominant manufacturers. No regulatory approval or launch timeline was announced, and pricing or Medicaid coverage decisions are not yet at issue. For Medicaid stakeholders, the news signals that pipeline competition in this drug class will continue to grow, with implications for future coverage and cost pressure once new products reach market.
- Industry
Study Finds Long COVID Persists Among Healthcare Workers
A new study finds that healthcare workers continue to experience persistent long COVID symptoms, compounding existing workforce burnout and staffing shortages. The findings affect hospitals, nursing facilities, and other providers that serve Medicaid patients and already face labor supply constraints. No specific policy action or effective date is described in this report. The study's findings matter for Medicaid stakeholders because provider workforce shortages directly affect beneficiary access to care, particularly in long-term care and safety-net settings that rely heavily on Medicaid reimbursement.
- Industry · AL
DCH Health System to End Fayette Medical Center Lease Early
DCH Health System and the Fayette County Hospital Board announced they will not continue their lease agreement for Fayette Medical Center, ending it ahead of its scheduled September 30, 2027 expiration. The arrangement began in October 2007 and covered 20 years of hospital operations in Fayette County, Alabama. The release cites financial factors as the reason for winding down the lease, though the exact termination date and transition plan were not detailed in the announcement. The change affects hospital governance and operations in the county, with implications for Medicaid beneficiaries who rely on the facility for care.
- Industry
Fair Health Reports Rising Commercial Delivery Costs Nationwide
Fair Health's Cost of Giving Birth tracker finds the median in-network cost of a vaginal delivery reached $15,728 nationally, up 3.6% year-over-year, while cesarean section costs rose 3.2% to $19,911. The analysis draws on commercial claims data and breaks out costs by state. The report does not address Medicaid-specific reimbursement rates or state Medicaid delivery costs, which are typically set separately through state fee schedules or managed care contracts. It matters for benchmarking maternity cost trends even though the underlying data reflects commercial, not Medicaid, payment levels.
- Industry
R1 Completes Acquisition of Prior Authorization AI Firm Humata Health
R1 has closed its acquisition of Humata Health, an AI-powered touchless prior authorization company, following an August announcement of the deal. The acquisition supports R1's stated strategy to automate revenue cycle operations through its Phare Operating platform. Health systems and providers using R1's revenue cycle services may see prior authorization workflows increasingly automated as the technology is integrated. The deal reflects broader industry investment in AI tools to speed up prior authorization, a process that affects Medicaid MCO utilization management and provider administrative burden.
- Industry
Insurers, Billing Vendors Clash Over AI's Impact on Health Costs
An insurance industry report claims that AI-powered billing tools used by providers could add billions of dollars in extra health spending. Billing technology companies dispute that framing, arguing the underlying problem is the complexity of the healthcare billing system itself rather than AI tools. Providers, payers, and billing vendors are affected as this dispute shapes how AI-driven coding and claims practices get scrutinized going forward. No specific effective date or regulatory action is described in the report.
- Industry
Bipartisan Federal Legislation Targets PBM Vertical Integration
Two states have enacted laws barring pharmacy benefit managers from owning retail pharmacies, addressing vertical integration models like CVS Health's. A federal bill with bipartisan sponsors would extend this prohibition nationwide. The proposal unites Republicans traditionally opposed to market intervention with Democrats more comfortable with regulatory oversight. For Medicaid managed care plans and carved-out PBM arrangements, any federal restriction on vertical integration would fundamentally reshape pharmacy network structures and vendor contracting options.
- Industry
Centene Reports Multiple Executive Departures Following $6.7 Billion Loss
Centene has experienced widespread leadership turnover in 2026, spanning state health plan executives to C-suite roles, following a $6.7 billion loss in 2025. The loss was primarily driven by a non-cash goodwill impairment related to HR 1 and the company's declining market value, alongside a 91.9% medical loss ratio. The departures signal organizational instability at one of the nation's largest Medicaid managed care organizations. Centene serves Medicaid beneficiaries across more than 30 states, making leadership continuity significant for state agency oversight and member care continuity.
Friday, September 25 · 7 stories
- Industry
Report Finds 340B Hospitals Spend Less on Charity Care Than Non-340B Peers
A new report finds hospitals participating in the 340B drug pricing program spend less on charity care than non-participating hospitals, contrary to the program's intent to support safety-net care. The findings intensify ongoing debate over 340B program integrity and whether participating hospitals deliver commensurate community benefits. Critics argue the program has expanded without corresponding patient benefits, while hospital groups dispute the methodology of such studies. The report has no immediate regulatory implications but may inform future congressional or CMS oversight of 340B hospital eligibility and accountability measures.
- Industry
Home-Based Care Providers Deploy AI, Outreach to Address Referral Bottlenecks
Home-based care providers report that referral processing, maintenance, and development remain persistent operational challenges, according to industry leaders interviewed by Home Health Care News. Companies are responding with AI-powered tools, clinician-led outreach initiatives, and strengthened relationships with franchise owner-operators to streamline referral workflows. These operational adjustments aim to reduce administrative friction in care coordination. For Medicaid managed LTSS and home and community-based services programs relying on home-based care networks, improvements in referral efficiency may affect network adequacy and care access.